TSE:TRL - Trilogy International Partners Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
C$2.44 -0.01 (-0.41 %)
(As of 02/22/2019 04:00 PM ET)
Previous CloseC$2.45
Today's RangeC$2.44 - C$2.45
52-Week RangeC$1.22 - C$5.79
Volume200,300 shs
Average Volume25,368 shs
Market CapitalizationC$131.82 million
P/E Ratio-4.44
Dividend Yield0.92%
BetaN/A
Trilogy International Partners Inc., together with its subsidiaries, provides wireless voice and data communications services to customers and international visitors roaming on its networks in the United States, Bolivia, and New Zealand. Its wireless voice and data communications services include local, international long distance, and roaming services. The Company also provides fixed broadband communications services to business and residential customers. It serves approximately 15.4 million customers. The company is headquartered in Bellevue, Washington.

Receive TRL News and Ratings via Email

Sign-up to receive the latest news and ratings for TRL and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Drug Manufacturers - Major
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone+1-425-4585900

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesC$791.59 million
Cash FlowC$0.72 per share
Book ValueC($1.24) per share

Profitability

Miscellaneous

Employees1,883
Market CapC$131.82 million
Next Earnings Date2/27/2019 (Estimated)
OptionableNot Optionable

Trilogy International Partners (TSE:TRL) Frequently Asked Questions

What is Trilogy International Partners' stock symbol?

Trilogy International Partners trades on the Toronto Stock Exchange (TSX) under the ticker symbol "TRL."

How often does Trilogy International Partners pay dividends? What is the dividend yield for Trilogy International Partners?

Trilogy International Partners declared a quarterly dividend on Friday, April 13th. Investors of record on Friday, May 4th will be given a dividend of 0.02 per share on Friday, May 4th. This represents a $0.08 annualized dividend and a yield of 3.28%. The ex-dividend date of this dividend is Friday, April 13th. View Trilogy International Partners' Dividend History.

When is Trilogy International Partners' next earnings date?

Trilogy International Partners is scheduled to release their next quarterly earnings announcement on Wednesday, February 27th 2019. View Earnings Estimates for Trilogy International Partners.

What price target have analysts set for TRL?

3 equities research analysts have issued twelve-month price objectives for Trilogy International Partners' stock. Their predictions range from C$3.00 to C$8.00. On average, they expect Trilogy International Partners' stock price to reach C$4.83 in the next twelve months. This suggests a possible upside of 98.1% from the stock's current price. View Analyst Price Targets for Trilogy International Partners.

What is the consensus analysts' recommendation for Trilogy International Partners?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Trilogy International Partners in the last year. There are currently 1 hold rating and 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Trilogy International Partners.

Has Trilogy International Partners been receiving favorable news coverage?

Media headlines about TRL stock have been trending somewhat positive recently, InfoTrie reports. The research firm identifies negative and positive media coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Trilogy International Partners earned a media sentiment score of 1.7 on InfoTrie's scale. They also assigned news stories about the specialty pharmaceutical company a news buzz of 10.0 out of 10, indicating that recent media coverage is extremely likely to have an impact on the stock's share price in the next several days.

Who are some of Trilogy International Partners' key competitors?

What other stocks do shareholders of Trilogy International Partners own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Trilogy International Partners investors own include Acerus Pharmaceuticals (ASP), Oncolytics Biotech (ONCYF), Millicom International Cellular (MIICF), Emera (EMA), Precision Drilling (PDS), CytomX Therapeutics (CTMX), Cboe Global Markets (CBOE), CSX (CSX), Jetpay (JTPY) and CAE (CAE).

Who are Trilogy International Partners' key executives?

Trilogy International Partners' management team includes the folowing people:
  • Mr. John William Stanton, Co-Founder, Chairman & Lead Director (Age 64)
  • Mr. Bradley Jay Horwitz, Co-Founder, Pres, CEO & Non-Independent Director (Age 63)
  • Ms. Theresa E. Gillespie, Co-Founder & Non-Independent Director (Age 66)
  • Mr. Erik Mickels, Sr. VP & CFO
  • Mr. Scott Morris, Sr. VP, Gen. Counsel & Corp. Sec.

How do I buy shares of Trilogy International Partners?

Shares of TRL and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.

What is Trilogy International Partners' stock price today?

One share of TRL stock can currently be purchased for approximately C$2.44.

How big of a company is Trilogy International Partners?

Trilogy International Partners has a market capitalization of C$131.82 million and generates C$791.59 million in revenue each year. Trilogy International Partners employs 1,883 workers across the globe.

What is Trilogy International Partners' official website?

The official website for Trilogy International Partners is http://www.trilogy-international.co....

How can I contact Trilogy International Partners?

Trilogy International Partners' mailing address is Bellevue Wa PO Box 1988, BELLEVUE, WA 98009-1988, United States. The specialty pharmaceutical company can be reached via phone at +1-425-4585900.


MarketBeat Community Rating for Trilogy International Partners (TSE TRL)

Community Ranking:  3.0 out of 5 (star star star)
Outperform Votes:  170 (Vote Outperform)
Underperform Votes:  110 (Vote Underperform)
Total Votes:  280
MarketBeat's community ratings are surveys of what our community members think about Trilogy International Partners and other stocks. Vote "Outperform" if you believe TRL will outperform the S&P 500 over the long term. Vote "Underperform" if you believe TRL will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/23/2019 by MarketBeat.com Staff

Featured Article: Bear Market

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel